Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Blood Products Advisory Committee

Executive Summary

Will meet Jan. 17 to discuss health issues concerning Yersinia infections in blood donations, donor deferral issues, and proposed criteria for an HIV "look-back" concerning products and recipient notification. On Jan. 18, the committee will address the premarket approval of Abbott's anti-hepatitis B core assay (anti-HBc) IgM test kit and anti-HBc donor deferral and re-entry issues. The committee will also discuss blood product safety issues concerning anti-Hepatitis C virus testing in source plasma donors. The meeting begins at 8:00 a.m. at the Ramada Inn in Bethesda, Md.
Advertisement
Advertisement
UsernamePublicRestriction

Register

PS018587

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel